More detailed analysis of tumor-infiltrating versus tdLN-resident CD8+ T cells after m1928z-CD40L CAR T cell treatment could help to delineate the logistics of cDC1-CD8+ T cell interactions. This evidence concerns the gene CD40LG and neoplasm.